Top Markets
Coin of the day
Onesource Specialty Pharma Ltd. Onesource Specialty Pharma Ltd.

Onesource Specialty Pharma Ltd.

ONESOURCE
株式のランク #6659
OneSource Specialty Pharma Limited is a biopharmaceutical company focused on... OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.
株価
$16.75
最終同期: 2026-08-27
時価総額
$1.92B
変化(1日)
2.28%
変化(1年)
-20.92%
IN
取引 Onesource Specialty Pharma Ltd. (ONESOURCE)

カテゴリー

Onesource Specialty Pharma Ltd.(ONESOURCE)の配当利回りの履歴
Onesource Specialty Pharma Ltd.(銘柄コード: ONESOURCE)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Onesource Specialty Pharma Ltd.(ONESOURCE)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)